; H2 2012 | Aarkstore.com || Neurofibromatoses – Pipeline Review, H2 2012
Learning Center
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

H2 2012 | Aarkstore.com || Neurofibromatoses – Pipeline Review, H2 2012


  • pg 1
									You can also request for sample page of above
mention reports on sample@aarkstore.com
Pages : 73

PDF - $ 2000 | Site Licence - $ 4000 $ | Enterprise License - $
6000 |

 Global Markets Direct’s, Retinitis Pigmentosa (Retinitis) - Pipeline Review,
H2 2012, provides an overview of the indication’s therapeutic pipeline. This
report provides information on the therapeutic development for Retinitis
Pigmentosa (Retinitis), complete with latest updates, and special features on
late-stage and discontinued projects. It also reviews key players involved in
the therapeutic development for Retinitis Pigmentosa (Retinitis). Retinitis
Pigmentosa (Retinitis) - Pipeline Review, Half Year is built using data and
information sourced from Global Markets Direct’s proprietary databases,
Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific
third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on
the availability and relevance of data for the indicated disease.

 - A snapshot of the global therapeutic scenario for Retinitis Pigmentosa
- A review of the Retinitis Pigmentosa (Retinitis) products under development
by companies and universities/research institutes based on information derived
from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined

Reasons to buy

- Identify and understand important and diverse types of therapeutics under
development for Retinitis Pigmentosa (Retinitis).
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline.
Table of Contents :

 List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Retinitis Pigmentosa (Retinitis) Overview 8
Therapeutics Development 9
An Overview of Pipeline Products for Retinitis Pigmentosa (Retinitis) 9
Retinitis Pigmentosa (Retinitis) Therapeutics under Development by
Companies 11
Retinitis Pigmentosa (Retinitis) Therapeutics under Investigation by
Universities/Institutes 13
Mid Clinical Stage Products 14
Comparative Analysis 14
Early Clinical Stage Products 15
Comparative Analysis 15
Discovery and Pre-Clinical Stage Products 16
Comparative Analysis 16
Retinitis Pigmentosa (Retinitis) Therapeutics – Products under Development
by Companies 17
Retinitis Pigmentosa (Retinitis) Therapeutics – Products under Investigation
by Universities/Institutes 18………………
Please follow link if you want More Related
Reports :

Pipeline Review, H2 2012

Review, H2 2012&PubId=&pagenum=1
Related Reports:

Hereditary Angioedema (HAE) – Pipeline Review, H2 2012
Dermatomycoses – Pipeline Review, H2 2012
Familial Adenomatous Polyposis Coli – Pipeline Review, H2 2012
Tinnitus – Pipeline Review, H2 2012
Premenstrual Syndrome – Pipeline Review, H2 2012
Wrinkles – Pipeline Review, H2 2012
Genital Warts (Condylomata Acuminata) – Pipeline Review, H2
Fabry Disease – Pipeline Review, H2 2012
Thyroid Gland Disorders – Pipeline Review, H2 2012
Proteinuria – Pipeline Review, H2 2012
Viral Conjunctivitis – Pipeline Review, H2 2012
Mixed Dyslipidemia – Pipeline Review, H2 2012
Keratitis – Pipeline Review, H2 2012
Generalized Seizures – Pipeline Review, H2 2012
Cataract – Pipeline Review, H2 2012
Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review,
H2 2012
Thrombocythaemia Myelofibrosis – Pipeline Review, H2 2012
For More details about above & other
Reports plz contact :


Contact: Marketing team Mob.No.918149852585
Email: enquiry@aarkstore.com ,
URL: http://www.aarkstore.com

To top